How "Pharmacoresistant" is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?
about
The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialDifferential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activationα-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors.
P2860
How "Pharmacoresistant" is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@en
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@nl
type
label
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@en
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@nl
prefLabel
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@en
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@nl
P2860
P356
P1433
P1476
How "Pharmacoresistant" is Cav ...... ge-Gated R-type Ca2+ Channels?
@en
P2093
Maxine Dibué
Toni Schneider
P2860
P304
P356
10.3390/PH6060759
P577
2013-05-27T00:00:00Z